Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

For many, depression persists after routine treatment

06.05.2004


Half of patients treated for depression in primary care facilities during a recent study still suffered from the condition 18 to 24 months later, according to recent research.



Patients who were unemployed, had suicidal thoughts at the beginning of the study and who stopped taking antidepressant medication on their own, before their doctor told them to quit the treatment were more likely to suffer persistent depression symptoms than those who recovered from depression over the course of the study, according to Catherine Sherbourne, Ph.D., of RAND and colleagues.

Their findings are published in the General Hospital Psychiatry.


Those with persistent depression were also the most likely to pursue aggressive therapy that combined medication and counseling sessions “suggesting that the persistent depression was not because of less intensive treatment and may represent true treatment resistance,” Sherbourne says.

Researchers and physicians need to learn more about the track record of depression treatment in primary care, since primary care settings like clinics and hospitals treat more than half of all depressed patients in the United States, the authors say.

“Relative to patients who recovered, patients with poor treatment responses continued to use both general medical and mental health specialty services of all types, placing a burden on themselves, friends and family and on the health care system,” Sherbourne says.

Sherbourne and colleagues followed the treatment outcomes for 1,248 people diagnosed with depression at 46 primary care clinics nationwide. Of this group, less than half received “minimally appropriate treatment” for their depression, defined as four or more special counseling sessions during six months or the use of approved antidepressant drugs for at least two months. Patients in the study could choose whether to receive therapy only, drugs only, a combination of the two or no treatment at all.

Only 442 patients received at least two six-month sessions of treatment. Of those patients, 261 people remained depressed and 181 had recovered from depression 18 to 24 months after the study started.

Patients with persistent depression were more likely than those who recovered to report side effects from their medication, to be in worse mental and physical health at the start of the study and to have sought prior treatment for depression. Patients who recovered were more likely to prefer counseling at the start of the study.

Those with persistent depression were also more likely to say they received less care from their doctors than they wanted. When asked why they did not seek further help, many said “they didn’t think they could be helped” or said they were too embarrassed or afraid to bring up the issue with their health care provider, Sherbourne says.

The study was supported by Eli Lilly and Co., which manufactures the antidepressant Prozac, the Agency for Healthcare Research and Quality, the National Institute of Mental Health and the John D. and Catherine T. MacArthur Foundation (which also supports the Health Behavior News Service).



Health Behavior News Service: (202) 387-2829 or www.hbns.org.
Interviews: Contact Catherine Sherbourne at cathy_sherbourne@rand.org.
General Hospital Psychiatry: Don R. Lipsitt, M.D., at (617) 661-3544.

Becky Ham | CAH
Further information:
http://www.cfah.org/hbns/news/routine05-05-04.cfm

More articles from Studies and Analyses:

nachricht Amputees can learn to control a robotic arm with their minds
28.11.2017 | University of Chicago Medical Center

nachricht The importance of biodiversity in forests could increase due to climate change
17.11.2017 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Midwife and signpost for photons

11.12.2017 | Physics and Astronomy

How do megacities impact coastal seas? Searching for evidence in Chinese marginal seas

11.12.2017 | Earth Sciences

PhoxTroT: Optical Interconnect Technologies Revolutionized Data Centers and HPC Systems

11.12.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>